Literature DB >> 23104281

Quality in the molecular microbiology laboratory.

Paul S Wallace1, William G MacKay.   

Abstract

In the clinical microbiology laboratory advances in nucleic acid detection, quantification, and sequence analysis have led to considerable improvements in the diagnosis, management, and monitoring of infectious diseases. Molecular diagnostic methods are routinely used to make clinical decisions based on when and how to treat a patient as well as monitor the effectiveness of a therapeutic regime and identify any potential drug resistant strains that may impact on the long term patient treatment program. Therefore, confidence in the reliability of the result provided by the laboratory service to the clinician is essential for patient treatment. Hence, suitable quality assurance and quality control measures are important to ensure that the laboratory methods and service meet the necessary regulatory requirements both at the national and international level. In essence, the modern clinical microbiology laboratory ensures the appropriateness of its services through a quality management system that monitors all aspects of the laboratory service pre- and post-analytical-from patient sample receipt to reporting of results, from checking and upholding staff competency within the laboratory to identifying areas for quality improvements within the service offered. For most European based clinical microbiology laboratories this means following the common International Standard Organization (ISO9001) framework and ISO15189 which sets out the quality management requirements for the medical laboratory (BS EN ISO 15189 (2003) Medical laboratories-particular requirements for quality and competence. British Standards Institute, Bristol, UK). In the United States clinical laboratories performing human diagnostic tests are regulated by the Centers for Medicare and Medicaid Services (CMS) following the requirements within the Clinical Laboratory Improvement Amendments document 1988 (CLIA-88). This chapter focuses on the key quality assurance and quality control requirements within the modern microbiology laboratory providing molecular diagnostics.

Entities:  

Mesh:

Year:  2013        PMID: 23104281     DOI: 10.1007/978-1-60327-353-4_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Duplex PCR methods for the molecular detection of Escherichia fergusonii isolates from broiler chickens.

Authors:  Karen Simmons; Heidi Rempel; Glenn Block; Vincenzo Forgetta; Rolland Vaillancourt; François Malouin; Edward Topp; Pascal Delaquis; Moussa S Diarra
Journal:  Appl Environ Microbiol       Date:  2014-01-17       Impact factor: 4.792

2.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

3.  Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.

Authors:  Wesley H Self; Derek J Williams; Yuwei Zhu; Krow Ampofo; Andrew T Pavia; James D Chappell; Weston C Hymas; Chris Stockmann; Anna M Bramley; Eileen Schneider; Dean Erdman; Lyn Finelli; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  J Infect Dis       Date:  2015-07-14       Impact factor: 5.226

4.  How to make Mathematics Biology's next and better microscope.

Authors:  Jim Huggett; Justin O'Grady; Stephen Bustin
Journal:  Biomol Detect Quantif       Date:  2014-09-10

5.  Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification.

Authors:  Guillaume Roux; Christophe Ravel; Emmanuelle Varlet-Marie; Rachel Jendrowiak; Patrick Bastien; Yvon Sterkers
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

Review 6.  Modern clinical microbiology: new challenges and solutions.

Authors:  Pierre-Edouard Fournier; Michel Drancourt; Philippe Colson; Jean-Marc Rolain; Bernard La Scola; Didier Raoult
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

Review 7.  Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19.

Authors:  Miroslav Pohanka
Journal:  Sensors (Basel)       Date:  2022-09-29       Impact factor: 3.847

8.  External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance.

Authors:  Sean C Murphy; Cornelus C Hermsen; Alexander D Douglas; Nick J Edwards; Ines Petersen; Gary A Fahle; Matthew Adams; Andrea A Berry; Zachary P Billman; Sarah C Gilbert; Matthew B Laurens; Odile Leroy; Kristen E Lyke; Christopher V Plowe; Annette M Seilie; Kathleen A Strauss; Karina Teelen; Adrian V S Hill; Robert W Sauerwein
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

9.  WHO malaria nucleic acid amplification test external quality assessment scheme: results of distribution programmes one to three.

Authors:  Jane A Cunningham; Rebecca M Thomson; Sean C Murphy; Maria de la Paz Ade; Xavier C Ding; Sandra Incardona; Eric Legrand; Naomi W Lucchi; Didier Menard; Samuel L Nsobya; Agatha C Saez; Peter L Chiodini; Jaya Shrivastava
Journal:  Malar J       Date:  2020-03-30       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.